Agilent Technologies, Inc. revenue by segment A

Annual Quarterly

Agilent Technologies, Inc. splits its revenue 2 ways in its filings. By operating segments, the largest line in Q3 of fiscal 2026, the quarter ended Jul 31, 2026 was Agilent Cross Lab at $786.0 million, 42% of the total. By sales mix, the largest line in Q3 of fiscal 2026, the quarter ended Jul 31, 2026 was Non Instrumentationand Other at $1.2 billion, 66% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Jul 31, 2026	Q3 FY2026 Jul 31, 2026	Q2 FY2026 Apr 30, 2026	Q1 FY2026 Jan 31, 2026	Q4 FY2025 Oct 31, 2025	Q3 FY2025 Jul 31, 2025	Q2 FY2025 Apr 30, 2025	Q1 FY2025 Jan 31, 2025	Q4 FY2024 Oct 31, 2024
Revenue	7,372	1,878	1,835	1,798	1,861	1,738	1,668	1,681	1,701
Operating segments
Agilent Cross Lab	3,058 +7.0% share 41.5%	786 +5.6% share 41.9%	759 +6.5% share 41.4%	758 +8.9% share 42.2%	755 +77.2% share 40.6%	744 share 42.8%	713 share 42.7%	696 share 41.4%	426 share 25.0%
Life Sciences And Diagnostics Markets	2,912 +10.8% share 39.5%	746 +11.3% share 39.7%	732 +11.9% share 39.9%	679 +4.9% share 37.8%	755 +14.9% share 40.6%	670 share 38.6%	654 share 39.2%	647 share 38.5%	657 share 38.6%
Applied Markets	1,402 +7.8% share 19.0%	346 +6.8% share 18.4%	344 +14.3% share 18.7%	361 +6.8% share 20.1%	351 +3.8% share 18.9%	324 share 18.6%	301 share 18.0%	338 share 20.1%	338 share 19.9%
Sales mix
Non Instrumentationand Other	4,800 +9.2% share 65.1%	1,235 +8.4% share 65.8%	1,217 +8.9% share 66.3%	1,140 +8.0% share 63.4%	1,208 +11.7% share 64.9%	1,139 share 65.5%	1,118 share 67.0%	1,056 share 62.8%	1,081 share 63.6%
Instrumentation	2,572 +7.4% share 34.9%	643 +7.3% share 34.2%	618 +12.4% share 33.7%	658 +5.3% share 36.6%	653 +5.3% share 35.1%	599 share 34.5%	550 share 33.0%	625 share 37.2%	620 share 36.4%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: A (NYSE)
Fiscal year ends: October 31
Incorporated in: DE
Headquarters: Santa Clara, CA
SEC filer status: Large accelerated filer
SEC CIK: 1090872
Former names: AGILENT TECHNOLOGIES INC (until Sep 16, 2019)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.